Bank Of America Corp Catalyst Biosciences, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.2 - $0.35 $3,271 - $5,724	16,355 Added 50.93%	48,468 $16,000
Q1 2023 May 12, 2023	BUY	$0.19 - $0.64 $1,816 - $6,120	9,563 Added 42.41%	32,113 $6,000
Q4 2022 Feb 10, 2023	BUY	$0.49 - $0.57 $32 - $37	66 Added 0.29%	22,550 $11,000
Q2 2022 Aug 12, 2022	SELL	$0.36 - $1.78 $802 - $3,967	-2,229 Reduced 9.02%	22,484 $40,000
Q1 2022 May 16, 2022	SELL	$0.51 - $1.0 $191 - $376	-376 Reduced 1.5%	24,713 $16,000
Q4 2021 Feb 08, 2022	SELL	$0.91 - $4.16 $791 - $3,619	-870 Reduced 3.35%	25,089 $23,000
Q3 2021 Nov 15, 2021	SELL	$3.78 - $5.18 $19,058 - $26,117	-5,042 Reduced 16.26%	25,959 $107,000
Q2 2021 Sep 13, 2021	BUY	$4.1 - $5.33 $127,104 - $165,235	31,001 New	31,001 $134,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.